Breaking The Mold On Breast Cancer

An interview with noted Hadassah oncologist Dr. Tamar Peretz on genetic testing, mammograms and why the one-size-fits-all protocol no longer makes sense.

Deputy Managing Editor
10/27/2015 - 20:00

Dr. Tamar Peretz is the director of Hadassah’s Sharett Institute of Oncology in Jerusalem and interim director general of the Hadassah Medical Organization in Jerusalem; at Hadassah, she leads the team whose genetic research and clinical studies have led to groundbreaking discoveries on BRCA1 gene mutations in the Ashkenazi community and new prevention, diagnosis and treatment approaches.

Dr. Tamar Peretz, left, with Fran Drescher at the Cancer Schmancer Women’s Health Summit in New York. Courtesy of Hadassah

Healthcare October 2015

An interview with noted Hadassah oncologist Dr. Tamar Peretz. New breast cancer stats: What’s an Ashkenazi woman to do? High anxiety over Israel’s medical marijuana laws.

10/26/2015 - 20:00
Healthcare October 2015

When Vaccinations And Faith Collide

Are anti-vaxxers’ religious exemption claims grounded in actual religious laws?

04/21/2015 - 20:00

As the debate on vaccination heats up again in the U.S., some “anti-vaxxers” are requesting exemptions from vaccinating their chil-dren on religious grounds. But what do their faiths, including Judaism, actually say about the issue?

A White House nurse prepares to administer the H1N1 vaccine to President Barack Obama on Dec. 20, 2009. Pete Souza/White House

The Silence Of Infertility

The physical, emotional and communal toll of not being able to have children.

Special To The Jewish Week
04/21/2015 - 20:00

When we were first married, about a decade ago, we lived in New York. We did not want to wait to have children; we wanted to begin a family right away.

Rachel and Will Adler, with Joey and Emily. Courtesy of Rachel and Will Adler

Bringing Genetic Screening Home

JScreen allows Jews to test for hereditary diseases with mail-in saliva test.

Staff Writer
04/21/2015 - 20:00

An innovative, Atlanta-based screening program for Jewish genetic diseases has expanded its geographic scope and medical capabilities since it was founded a year and a half ago — and, with the help of one supporter from Long Island, recently reached nearly 200 Jewish college students on one campus in one day.

Hillary Kener, JScreen’s national outreach director. Courtesy of JScreen

Giving The Overactive Mind A ‘Lift’

ADHD ‘brain-training’ app gaining traction.

Israel Correspondent
04/21/2015 - 20:00

Jerusalem — A pair of young Israeli entrepreneurs have developed an ADHD treatment app that they say will soon provide an affordable and readily accessible alternative to ADHD medications and prohibitively expensive brain-training (cognitive) treatments already being offered at specialized clinics. 

A promotional photo for the Myndlift app. Courtesy of Myndlift

Mail-In Test Puts Genetic Screening Within Reach

Home screening kits making BRCA testing increasingly affordable for women paying out of pocket.

Staff Writer
04/21/2015 - 20:00

Silicon Valley star Elad Gil’s new genetic testing company, launched Tuesday, has intensified the already noisy conversation about Ashkenazi Jews’ higher-than-normal risk for breast cancer.

Fighting Genetic Disease Among The Bedouins

Ben-Gurion University team seen making headway with testing, outreach.

Israel Correspondent
04/21/2015 - 20:00

There has been a 30 percent reduction in the infant mortality rate in Israel’s Bedouin community of southern Israel during the past few years, and much of that success is due to the diagnosis and prevention of many genetic diseases that have plagued the community for centuries Much of the research into these diseases, which can cause everything from severe developmental delays and fatal heart malformations to blindness and immune deficiencies, has been taking place in the southern city of Beersheva under the leadership of Dr. Ohad Birk. 

Dr. Ohad Birk, left, with Dr. Khalil Elbedour in a Bedouin village. Courtesy of Ben-Gurion University

Healthcare April 2015

Battling genetic disease among the Bedouins. Silicon Valley BRCA testing kit making waves in market. Atlanta-based screening program expanding reach. Israeli app for ADHD gaining traction. The silence of infertility.

04/21/2015 - 20:00
Healthcare April 2015

New Subsidy For Breast Cancer Testing

Einstein-affiliated Jewish genetic health program joins with Montefiore on BRCA1/2 screening.

Managing Editor
01/20/2015 - 19:00

Beginning this week, the Program for Jewish Genetic Health, a nonprofit affiliated with Yeshiva University and the school’s Albert Einstein College of Medicine, is teaming up with Montefiore Health System to offer subsidized genetic testing for Ashkenazi women and men who might be carriers of the BRCA1/2 genes for breast cancer. The cost for the test is $100. To discuss the test and broader questions about breast cancer, The Jewish Week spoke with Dr. Susan Klugman, medical director for the Program for Jewish Genetic Health, director of the division of reproductive genetics at Montefiore, and professor of clinical obstetrics and gynecology and women’s health at Einstein. The interview was conducted via email.

Dr. Susan Klugman
Syndicate content